Company: HYEX
Filing Date: 2025-04-22
Form Type: 10-K/A
Source: 0001096906-25-000553
Chunk: 51

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-22
Form: 10-K/A
Chunk 51
---
 |              $4.29 |     | $1.01 |
|              |     | Second Quarter                         |     |              $2.50 |     | $0.91 |
|              |     | First Quarter                          |     |              $4.05 |     | $1.03 |
| 2023         |     | Fourth Quarter                         |     |              $7.20 |     | $3.24 |
|              |     | Third Quarter                          |     |              $7.20 |     | $3.60 |
|              |     | Second Quarter                         |     |              $6.96 |     | $5.50 |
|              |     | First Quarter                          |     |              $7.02 |     | $4.32 |

The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosure relating to the market for penny stocks in connection with trades in any stock defined as a penny stock. The Commission has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to a few exceptions which we do not meet. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated therewith. Holders As of March 14, 2025, there were 2,989,406 shares of our common stock issued and outstanding and held by approximately 110 holders of record, not including shares held in “street name” in brokerage accounts which is unknown. Dividend Policy We have not paid any dividends on our common stock and do not expect to do so in the foreseeable future. We intend to apply our earnings, if any, in expanding our operations and related activities. The payment of cash dividends in the future will be at the discretion of the Board of Directors and will depend upon such factors as earnings levels, capital requirements, our financial condition and other factors deemed relevant by the Board of Directors. 41 Securities Authorized for Issuance under Equity Compensation Plans On December 26, 2022, we approved the Healthy Extracts Inc. 2022 Equity Incentive Plan and set aside 433,334 shares of our common stock for issuance thereunder.

| Plan category                                              | Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future